Recovery, De-Escalation, and Transition of Care in ICU Delirium, Agitation & Anxiety

1. Weaning and De-Escalation Protocols

As neurologic function improves, structured daily sedation interruption (SAT) and spontaneous breathing trial (SBT) protocols reduce delirium duration and ventilator days while maintaining safety.

Eligibility and Procedure for SAT/SBT

Eligibility for SATs: Hemodynamic stability (no escalating vasopressors in past 2 hours), FiO₂ ≤ 60% and PEEP ≤ 10 cm H₂O, and not receiving neuromuscular blockers.
SAT Procedure: Stop all continuous sedatives. Assess Richmond Agitation-Sedation Scale (RASS) every 10–15 minutes for up to 60 minutes. If the SAT is successful (RASS ≥ –2 and no adverse events), resume sedation at 50% of the prior dose and titrate to a target RASS of –1 to 0.
SAT + SBT Pairing: Immediately follow a successful SAT with an SBT (using a T-piece or low pressure support ventilation). Failure criteria include respiratory rate > 35 breaths/min, SpO₂ < 88%, heart rate > 140 bpm, or signs of respiratory distress. If failed, revert to prior ventilator settings and plan to retry in 24 hours.
Safety Stop Criteria: Immediately stop the trial and reinstate sedation for SpO₂ < 88%, mean arterial pressure (MAP) < 60 mmHg, or RASS > +2. Re-evaluate for another trial every 4 hours.

Clinical Pearls

Protocolized pairing of SAT and SBT has been shown to shorten total sedation exposure, reduce ventilator days, and decrease ICU length of stay.
Conducting these trials during multidisciplinary rounds ensures consistent execution, clear communication, and accurate documentation among the care team.

2. IV-to-Enteral Conversion Strategies

Transitioning from intravenous (IV) sedatives and analgesics to enteral formulations is a key step that reduces line-related complications and facilitates step-down care. However, clinicians must be aware that absorption can be unpredictable in critically ill patients.

Pharmacokinetic Considerations

Critical illness significantly alters drug absorption due to several factors:

Splanchnic Hypoperfusion: Reduced blood flow to the gut can impair drug uptake.
Mucosal Edema and Ileus: Swelling of the gut lining and delayed gastric emptying can lead to erratic absorption.
Mitigation Strategies: Using post-pyloric feeding tubes and administering prokinetic agents (e.g., metoclopramide 10 mg q6h) may improve drug delivery and absorption.

Dose Equivalency & Cross-Titration

Approximate IV-to-Enteral Dose Conversions for Sedatives
IV Agent	IV Rate	PO Equivalent	Bioavailability	Titration Guidance
Lorazepam	1 mg IV q6h	2.5 mg PO q6h (Ratio ~1:2.5)	~90%	Increase by 0.5–1 mg every 24h
Midazolam	1 mg/hr infusion	7.5 mg PO q8h (Ratio ~1:7.5)	40–50%	Increase by 2.5 mg every 8–12h
Hydroxyzine	—	50 mg PO q12h	—	Adjust for hepatic function
Melatonin	—	3–10 mg PO qhs	—	Increase by 1–3 mg nightly

Cross-Titration Plan

Start the enteral agent at 25–50% of the target dose while the IV infusion is still running.
Over the next 12–24 hours, gradually decrease the IV infusion rate by 10–20% per interval as the enteral dose is uptitrated.
Continuously monitor RASS (target –2 to 0) and observe for signs of withdrawal, such as agitation, hypertension, or tachycardia.

Common Pitfalls

Tapering the IV medication too rapidly in a patient with poor enteral absorption can precipitate acute withdrawal.
Failing to check enteral tube position and measure gastric residuals before administering doses can lead to therapeutic failure or aspiration.

3. Mitigation of Post-ICU Syndrome (PICS)

Post-ICU Syndrome (PICS) is a constellation of physical, cognitive, and psychological impairments that persist long after discharge. Implementing the ABCDEF bundle and promoting early rehabilitation are the most effective strategies to reduce its incidence and severity.

Figure 1: The ABCDEF Bundle. A multicomponent, evidence-based organizational approach to improve communication among ICU team members, standardize care processes, and reduce long-term consequences of critical illness.

Early Mobilization & Cognitive Rehab

Initiate passive range-of-motion exercises on day 1 of ICU admission.
Progress as tolerated to in-bed cycling, sitting at the edge of the bed, and ambulation when feasible.
Provide cognitive stimulation through frequent reorientation, memory tasks, and placing clocks and calendars at the bedside.

Psychological Screening & Support

Use validated screening tools like the Hospital Anxiety and Depression Scale (HADS) or encourage ICU diaries to identify patients at high risk for PTSD.
Coordinate early referrals to psychology or psychiatry for high-risk patients before discharge.

4. Medication Reconciliation & Discharge Counseling

A thorough review of ICU and pre-admission medications is critical to identify and deprescribe deliriogenic agents. Clear patient and caregiver education is essential for ensuring a safe transition of care.

A. Deprescribing Deliriogenic Medications

Identify Culprits: Systematically review the medication list for agents introduced in the ICU, particularly benzodiazepines, anticholinergics, and long-acting opioids.
Develop a Taper Plan: For agents like benzodiazepines, create a structured taper schedule (e.g., 10–20% dose reduction daily) to prevent withdrawal.

B. Discharge Medication List & Education Tools

Reconcile Lists: Carefully reconcile the patient’s home medication list with the ICU list. Reinstate baseline neuropsychiatric drugs as soon as it is safe to do so.
Provide Clear Instructions: Create a patient-friendly medication schedule that includes drug names, simple indications, and dosing times.

C. Key Counseling Topics

Sleep Hygiene: Advise on maintaining a consistent bedtime, minimizing nighttime stimuli, and avoiding daytime napping.
Pain Control: Encourage the use of non-opioid analgesics like acetaminophen or NSAIDs as first-line options.
Warning Signs: Educate the patient and family on recognizing signs of confusion, agitation, or withdrawal symptoms and when to seek medical help.
Follow-Up: Arrange a follow-up appointment within 7 days specifically to reassess cognitive status and functional ability.

Clinical Pearl

Integrating standardized discharge summary templates into the electronic health record (EHR) that specifically prompt for delirium history and medication reconciliation can significantly reduce medication errors and hospital readmissions.

5. Interdisciplinary Handoff & Long-Term Planning

Structured communication between care teams and coordinated referrals to outpatient services are vital for optimizing a patient’s recovery trajectory and ensuring continuity of care after ICU discharge.

A. Handoff Templates

Utilize a standardized handoff tool like SBAR (Situation, Background, Assessment, Recommendation) to convey critical information, including delirium history, total sedation exposure, SAT/SBT performance, and overall PICS risk.

B. Team Coordination and Referrals

Engage palliative care for goals-of-care discussions if cognitive impairment is prolonged or recovery is uncertain.
Establish clear referral triggers, such as persistent delirium lasting more than one month, which should prompt a neurology consult for formal neuropsychological testing.
Arrange for physical, occupational, and speech therapy outpatient services prior to the patient’s discharge.

C. Follow-Up & Quality Metrics

Schedule a follow-up appointment at a dedicated PICS clinic or with the primary care provider within two weeks of discharge.
Track key quality metrics, including readmission rates for delirium or withdrawal, patient-reported outcome measures (PROMs), and unit-wide adherence to the ABCDEF bundle.

Key Pearls

Early enrollment in a comprehensive rehabilitation program has been shown to reduce 6-month functional deficits and hospital readmissions.
Using quality dashboards to display bundle adherence and patient outcomes can drive multidisciplinary accountability and continuous process improvement.

References

Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult ICU patients. Crit Care Med. 2018;46(9):e825-e873.
Pun BT, Balas MC, Barnes-Daly MA, et al. Effectiveness of bundle interventions on ICU delirium. Crit Care Med. 2021;49(2):e123-e134.
Bellani G, Foti G, L’Acqua C, et al. Enteral vs intravenous ICU sedation management: a randomized controlled trial. Crit Care. 2013;17(2):R67.
Bellani G, Laffey JG, Pham T, et al. Enteral versus intravenous approach for sedation of critically ill patients: a multicenter randomized trial. Crit Care. 2019;23(1):8.
Children’s Hospital of Philadelphia Clinical Pathways Team. Sedation/Analgesia for Mechanically Ventilated PICU Patients Clinical Pathway. 2025.
Ankravs MJ, McKenzie CA, Kenes MT. Precision-based approaches to delirium in critical illness: A narrative review. Pharmacotherapy. 2023;43(11):1139-1153.
Roberts J. Weaning strategies in the ICU for ventilated patients. Respiratory Therapy. 2023.
Hick JL, Hanfling D, Wynia MK, Pavia AT. Crisis standards of care: de-escalation of care. ASPR TRACIE. 2020.

Learning Objective